0001209191-13-058659.txt : 20131226 0001209191-13-058659.hdr.sgml : 20131225 20131226161254 ACCESSION NUMBER: 0001209191-13-058659 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131223 FILED AS OF DATE: 20131226 DATE AS OF CHANGE: 20131226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6173416100 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SACHS BRUCE I CENTRAL INDEX KEY: 0001197036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 131298833 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-12-23 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197036 SACHS BRUCE I C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2013-12-23 4 S 0 7100 72.95 D 47710 D Common Stock 2013-12-23 4 S 0 1200 73.45 D 46510 D Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $72.95 (range $72.33 to $73.30). Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $73.45 (range $73.33 to $73.63). Omar White, Attorney-In-Fact 2013-12-26